7 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Immune Response Features Following Vaccination With a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)Respiratory Syncytial Virus (RSV)Not yet recruitingNot applicable2026-06-01NCT07618325
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)Respiratory Syncytial Virus (RSV)RecruitingPhase 32025-12-09NCT07272434
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and AboveRespiratory Syncytial Virus (RSV)Active, not recruitingPhase 1 / Phase 22025-06-06NCT06642558
Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and AboveDNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious diseaseActive, not recruitingPhase 22024-11-20NCT05856084
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and AboveDNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious diseaseActive, not recruitingPhase 12024-11-20NCT05636436
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and ToddlersDigestive System Diseases, Infections, RNA Virus Infections, Reoviridae infectious disease, Rotavirus infection, digestive system disorder, gastroenteritis, viral infectious diseaseActive, not recruitingPhase 22024-11-20NCT05621655
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 YearsDNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted diseaseActive, not recruitingPhase 32023-09-18NCT06041061